BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18260125)

  • 1. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.
    Wittmann S; Wunder C; Zirn B; Furtwängler R; Wegert J; Graf N; Gessler M
    Genes Chromosomes Cancer; 2008 May; 47(5):386-95. PubMed ID: 18260125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene expression signature for relapse of primary wilms tumors.
    Li W; Kessler P; Yeger H; Alami J; Reeve AE; Heathcott R; Skeen J; Williams BR
    Cancer Res; 2005 Apr; 65(7):2592-601. PubMed ID: 15805255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines.
    Williams RD; Hing SN; Greer BT; Whiteford CC; Wei JS; Natrajan R; Kelsey A; Rogers S; Campbell C; Pritchard-Jones K; Khan J
    Genes Chromosomes Cancer; 2004 Sep; 41(1):65-79. PubMed ID: 15236318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.
    Dome JS; Bockhold CA; Li SM; Baker SD; Green DM; Perlman EJ; Hill DA; Breslow NE
    J Clin Oncol; 2005 Dec; 23(36):9138-45. PubMed ID: 16172460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
    Chen QR; Bilke S; Wei JS; Greer BT; Steinberg SM; Westermann F; Schwab M; Khan J
    Genes Chromosomes Cancer; 2006 Sep; 45(9):856-62. PubMed ID: 16804916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of malignant pediatric renal tumors by gene expression.
    Huang CC; Cutcliffe C; Coffin C; Sorensen PH; Beckwith JB; Perlman EJ;
    Pediatr Blood Cancer; 2006 Jun; 46(7):728-38. PubMed ID: 16425275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling reveals MSX1 and EphB2 expression correlates with the invasion capacity of Wilms tumors.
    Chetcuti A; Aktas S; Mackie N; Ulger C; Toruner G; Alkan M; Catchpoole D
    Pediatr Blood Cancer; 2011 Dec; 57(6):950-7. PubMed ID: 21387540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of chromosomal aneuploidy from gene expression data.
    Hertzberg L; Betts DR; Raimondi SC; Schäfer BW; Notterman DA; Domany E; Izraeli S
    Genes Chromosomes Cancer; 2007 Jan; 46(1):75-86. PubMed ID: 17044051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
    Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
    Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S; Zirn B; Alkassar M; Ambros P; Graf N; Gessler M
    Genes Chromosomes Cancer; 2007 Feb; 46(2):163-70. PubMed ID: 17099873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia.
    Li W; Kessler P; Williams BR
    Oncogene; 2005 Jan; 24(3):457-68. PubMed ID: 15531917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
    Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
    Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.